Literature DB >> 26303947

UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1.

Hee-Joo Choi1, Ji-Hye Park2, Mikyung Park3, Hee-Young Won1, Hyeong-Seok Joo1, Chang Hoon Lee3, Jeong-Yeon Lee4, Gu Kong5.   

Abstract

The histone H3K27 demethylase, UTX, is a known component of the H3K4 methyltransferase MLL complex, but its functional association with H3K4 methylation in human cancers remains largely unknown. Here we demonstrate that UTX loss induces epithelial-mesenchymal transition (EMT)-mediated breast cancer stem cell (CSC) properties by increasing the expression of the SNAIL, ZEB1 and ZEB2 EMT transcription factors (EMT-TFs) and of the transcriptional repressor CDH1. UTX facilitates the epigenetic silencing of EMT-TFs by inducing competition between MLL4 and the H3K4 demethylase LSD1. EMT-TF promoters are occupied by c-Myc and MLL4, and UTX recognizes these proteins, interrupting their transcriptional activation function. UTX decreases H3K4me2 and H3 acetylation at these promoters by forming a transcriptional repressive complex with LSD1, HDAC1 and DNMT1. Taken together, our findings indicate that UTX is a prominent tumour suppressor that functions as a negative regulator of EMT-induced CSC-like properties by epigenetically repressing EMT-TFs.
© 2015 The Authors.

Entities:  

Keywords:  EMT; UTX; breast CSC

Mesh:

Substances:

Year:  2015        PMID: 26303947      PMCID: PMC4766458          DOI: 10.15252/embr.201540244

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  39 in total

1.  The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1.

Authors:  Yiwei Lin; Yadi Wu; Junlin Li; Chenfang Dong; Xiaofeng Ye; Young-In Chi; B Mark Evers; Binhua P Zhou
Journal:  EMBO J       Date:  2010-04-13       Impact factor: 11.598

2.  Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.

Authors:  T Lin; A Ponn; X Hu; B K Law; J Lu
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

3.  The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia.

Authors:  Joni Van der Meulen; Viraj Sanghvi; Konstantinos Mavrakis; Kaat Durinck; Fang Fang; Filip Matthijssens; Pieter Rondou; Monica Rosen; Tim Pieters; Peter Vandenberghe; Eric Delabesse; Tim Lammens; Barbara De Moerloose; Björn Menten; Nadine Van Roy; Bruno Verhasselt; Bruce Poppe; Yves Benoit; Tom Taghon; Ari M Melnick; Frank Speleman; Hans-Guido Wendel; Pieter Van Vlierberghe
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

Review 4.  Cells of origin in cancer.

Authors:  Jane E Visvader
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

5.  Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.

Authors:  Min Gyu Lee; Raffaella Villa; Patrick Trojer; Jessica Norman; Kai-Ping Yan; Danny Reinberg; Luciano Di Croce; Ramin Shiekhattar
Journal:  Science       Date:  2007-08-30       Impact factor: 47.728

6.  FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.

Authors:  Brett G Hollier; Agata A Tinnirello; Steven J Werden; Kurt W Evans; Joseph H Taube; Tapasree Roy Sarkar; Nathalie Sphyris; Maryam Shariati; Sreedevi V Kumar; Venkata L Battula; Jason I Herschkowitz; Rudy Guerra; Jeffrey T Chang; Naoyuki Miura; Jeffrey M Rosen; Sendurai A Mani
Journal:  Cancer Res       Date:  2013-02-01       Impact factor: 12.701

7.  Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.

Authors:  Soyoung Lim; Andreas Janzer; Astrid Becker; Andreas Zimmer; Roland Schüle; Reinhard Buettner; Jutta Kirfel
Journal:  Carcinogenesis       Date:  2009-12-30       Impact factor: 4.944

8.  The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming.

Authors:  Abed AlFatah Mansour; Ohad Gafni; Leehee Weinberger; Asaf Zviran; Muneef Ayyash; Yoach Rais; Vladislav Krupalnik; Mirie Zerbib; Daniela Amann-Zalcenstein; Itay Maza; Shay Geula; Sergey Viukov; Liad Holtzman; Ariel Pribluda; Eli Canaani; Shirley Horn-Saban; Ido Amit; Noa Novershtern; Jacob H Hanna
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

Review 9.  Roles of the Polycomb group proteins in stem cells and cancer.

Authors:  H Richly; L Aloia; L Di Croce
Journal:  Cell Death Dis       Date:  2011-09-01       Impact factor: 8.469

10.  Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia.

Authors:  Panagiotis Ntziachristos; Aristotelis Tsirigos; G Grant Welstead; Thomas Trimarchi; Sofia Bakogianni; Luyao Xu; Evangelia Loizou; Linda Holmfeldt; Alexandros Strikoudis; Bryan King; Jasper Mullenders; Jared Becksfort; Jelena Nedjic; Elisabeth Paietta; Martin S Tallman; Jacob M Rowe; Giovanni Tonon; Takashi Satoh; Laurens Kruidenier; Rab Prinjha; Shizuo Akira; Pieter Van Vlierberghe; Adolfo A Ferrando; Rudolf Jaenisch; Charles G Mullighan; Iannis Aifantis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

View more
  47 in total

1.  Histone demethylase UTX is a therapeutic target for diabetic kidney disease.

Authors:  Hong Chen; Yixue Huang; Xiuqin Zhu; Chong Liu; Yangmian Yuan; Hua Su; Chun Zhang; Chengyu Liu; Mingrui Xiong; Yannan Qu; Peng Yun; Ling Zheng; Kun Huang
Journal:  J Physiol       Date:  2018-12-25       Impact factor: 5.182

Review 2.  Epigenetic regulation of epithelial-mesenchymal transition.

Authors:  Lidong Sun; Jia Fang
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

3.  Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Takahiro Kodama; Justin Y Newberg; Michiko Kodama; Roberto Rangel; Kosuke Yoshihara; Jean C Tien; Pamela H Parsons; Hao Wu; Milton J Finegold; Neal G Copeland; Nancy A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

Review 4.  Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.

Authors:  Tong Chen; Yanan You; Hua Jiang; Zack Z Wang
Journal:  J Cell Physiol       Date:  2017-04-10       Impact factor: 6.384

5.  FAT4 functions as a tumor suppressor in triple-negative breast cancer.

Authors:  Lingmi Hou; Maoshan Chen; Xiaobo Zhao; Jingdong Li; Shishan Deng; Jiani Hu; Hongwei Yang; Jun Jiang
Journal:  Tumour Biol       Date:  2016-11-28

6.  [Effect of aberrant H3K27me3 modification in promoter regions on cAMP response element modulator α expression in CD4+ T cells from patients with systemic lupus erythematosus].

Authors:  Qing Zhang; Shu Ding; Hui-Lin Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

7.  Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma.

Authors:  Alex Panaccione; Yi Zhang; Yanfang Mi; Yoshitsugu Mitani; Guo Yan; Manju L Prasad; W Hayes McDonald; Adel K El-Naggar; Wendell G Yarbrough; Sergey V Ivanov
Journal:  Oral Oncol       Date:  2017-01-09       Impact factor: 5.337

Review 8.  Transcriptional deregulation underlying the pathogenesis of small cell lung cancer.

Authors:  Dong-Wook Kim; Keun-Cheol Kim; Kee-Beom Kim; Colin T Dunn; Kwon-Sik Park
Journal:  Transl Lung Cancer Res       Date:  2018-02

Review 9.  H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.

Authors:  J N Nichol; D Dupéré-Richer; T Ezponda; J D Licht; W H Miller
Journal:  Adv Cancer Res       Date:  2016-06-17       Impact factor: 6.242

Review 10.  Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.

Authors:  Jeong-Yeon Lee; Gu Kong
Journal:  Cell Mol Life Sci       Date:  2016-07-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.